4BIO Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round

4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery

Orchard Therapeutics Receives EC Approval for Treatment of Early-Onset Metachromatic Leukodystrophy

Appointment of Professor Akiko Iwasaki to Scientific Advisory Board

ADC Therapeutics Announces FDA’s Acceptance of its Biologics License Application

4BIO Capital invests in Araris Biotech AG’s CHF 15.2 million seed financing round